529 filings
Page 5 of 27
8-K
zwq7n
3 May 22
Heat Biologics Completes Name Change to NightHawk Biosciences; Trading to Commence Under “NHWK” Effective at the Market Open Today
7:15am
8-K
0ebj6ykzox iu8gjf7q
25 Apr 22
Other Events
8:00am
8-K
230n8c 32wj
20 Apr 22
Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys Therapeutics
8:06am
8-K
a6ztmd ufoebju9pg
18 Apr 22
Heat Biologics’ Scorpion Subsidiary Announces Planned Development of New Kansas Commercial/Biodefense Biomanufacturing Facility
8:35am
8-K
22ui4wui
24 Mar 22
Other Events
9:00am
8-K
y9rt197
14 Mar 22
Heat Biologics Provides Year-End 2021 Business Update
8:05am
8-A12B/A
ax47az0zq
11 Mar 22
Registration of securities on exchange (amended)
6:32am
8-K
2aljoseam hkl1og
11 Mar 22
Entry into a Material Definitive Agreement
6:28am
8-K
vrhlf
2 Mar 22
Other Events
4:05pm
25
1rbn1v26gh
11 Feb 22
Voluntary exchange delisting
12:00am
CERT
o3ryd2zo06q4 we
8 Feb 22
Certification of approval for exchange listing
5:03pm
8-A12B
mj3zmw80xn1ahmy0
4 Feb 22
Registration of securities on exchange
4:33pm
8-K
7ptylaoi2u8nll
3 Feb 22
Other Events
4:05pm
8-K
tl2y8
2 Feb 22
Heat Biologics Announces Planned Transfer to the NYSE American
4:41pm
8-K
5svcwhb913 np
12 Jan 22
Heat Biologics Announces New PTX-35 Preclinical Data in Organ Transplantation and Provides Update on HS-110
8:05am
8-K
jhwdk6
5 Jan 22
Regulation FD Disclosure
6:03am
8-K
9py5ujy5
3 Jan 22
Departure of Directors or Certain Officers
5:16pm
8-K
fya3qtvl7
21 Dec 21
Heat Biologics Announces Planned Acquisition of Elusys Therapeutics
5:03pm
8-K
jel45lf
15 Dec 21
Departure of Directors or Certain Officers
5:14pm